Preprint Open Access

Purification of ACVR1 alone and TGFBR1 (ALK5) complexed with FKBP12

Adamson, Roslin; Brennan, Paul; Mateucci, Mizio; Bullock, Alex

Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="" xmlns:oai_dc="" xmlns:xsi="" xsi:schemaLocation="">
  <dc:creator>Adamson, Roslin</dc:creator>
  <dc:creator>Brennan, Paul</dc:creator>
  <dc:creator>Mateucci, Mizio</dc:creator>
  <dc:creator>Bullock, Alex</dc:creator>
  <dc:description>Purifications of ALK2 and ALK5 (the latter in complex with FKBP12) and crystal hits</dc:description>
  <dc:description>The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA Darmstadt Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome [106169/ZZ14/Z].</dc:description>
  <dc:subject>ALK2, ALK5, ACVR1, TGFBR1, FKBP12, crystallisation</dc:subject>
  <dc:title>Purification of ACVR1 alone and TGFBR1 (ALK5) complexed with FKBP12</dc:title>
All versions This version
Views 9292
Downloads 4949
Data volume 54.8 MB54.8 MB
Unique views 7777
Unique downloads 2525


Cite as